https://www.indianpharmapost.com/mylab-launches-coviswift-for-covid-19-point-of-care-testing-111832022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-impresses-on-sustainability-and-gender-equality-again-111842022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/pristyn-care-doubles-it-surgical-centres-to-800-in-2021-111852022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/cadila-healthcare-reports-q3fy22-net-profit-at-rs-5004-cr-111862022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-receives-anda-approval-for-anti-depressant-medication-111872022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/universal-vaccination-for-covid-19-irrational-aiims-professor-111882022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/caplin-point-q3fy22-pat-at-rs-7495-cr-111892022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-first-generic-of-restasis-111902022-02-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-set-to-acquire-nimbus-health-111912022-02-03T00:00:00+05:30always0.9